Role of IL12 as an anti-tumour agent: Current status and future directions - Response

被引：0
|
作者：
Brunda
机构：
来源：
RESEARCH IN IMMUNOLOGY | 1995年 / 146卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：628 / 628
页数：1
相关论文
共 50 条
  • [1] Role of IL12 as an anti-tumour agent: Current status and future directions
    Brunda, MJ
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 622 - 627
  • [2] Role of IL12 as an anti-tumour agent: Current status and future directions - Commentary
    Fujiwara
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 627 - 627
  • [3] Role of interleukin-12 (IL12) as an anti-tumour agent: Experimental biology and clinical application
    Zitvogel, L
    Lotze, MT
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 628 - 635
  • [4] Role of interleukin-12 (IL12) as an anti-tumour agent: Experimental biology and clinical application - Commentary
    Fujiwara
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 636 - 636
  • [5] TAMOXIFEN AS AN ANTI-TUMOUR AGENT - ROLE OF ESTRADIOL AND PROLACTIN
    JORDAN, VC
    KOERNER, S
    JOURNAL OF ENDOCRINOLOGY, 1976, 68 (02) : 305 - 311
  • [6] The role of polyamine catabolism in anti-tumour drug response
    Casero, RA
    Wang, Y
    Stewart, TM
    Devereux, W
    Hacker, A
    Wang, Y
    Smith, R
    Woster, PM
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 361 - 365
  • [7] Anti-tumour necrosis factor (TNF) α treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13
    Pittoni, V
    Bombardieri, M
    Spinelli, FR
    Scrivo, R
    Alessandri, C
    Conti, F
    Spadaro, A
    Valesini, G
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (08) : 723 - 725
  • [8] PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
    Marcus Unterrainer
    Michael Ruzicka
    Matthias P. Fabritius
    Lena M. Mittlmeier
    Michael Winkelmann
    Johannes Rübenthaler
    Matthias Brendel
    Marion Subklewe
    Michael von Bergwelt-Baildon
    Jens Ricke
    Wolfgang G. Kunz
    Clemens C. Cyran
    European Radiology Experimental, 4
  • [9] PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
    Unterrainer, Marcus
    Ruzicka, Michael
    Fabritius, Matthias P.
    Mittlmeier, Lena M.
    Winkelmann, Michael
    Rubenthaler, Johannes
    Brendel, Matthias
    Subklewe, Marion
    von Bergwelt-Baildon, Michael
    Ricke, Jens
    Kunz, Wolfgang G.
    Cyran, Clemens C.
    EUROPEAN RADIOLOGY EXPERIMENTAL, 2020, 4 (01)
  • [10] Anti-tumour necrosis factor-α therapy in heart failure:: Future directions
    Balakumar, Pitchai
    Singh, Manjeet
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 (06) : 391 - 397
12345